Physical Activity and Fibrosing Interstitial Lung Disease

Recruiting N/A Interventional Study
Fibrotic Interstitial Lungs Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
60 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Fibrotic interstitial lungs diseases (ILD) are a group of chronic and rare diseases characterized by an altered blood oxygenation in the lung, leading to dyspnea and physical limitation. Physical training is efficient to fight vicious circle of physical deconditioning observed in ILD. Eccentric cycling is an interesting modality of endurance training, allowing better exercise tolerance and adheren…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient aged ≥ 18 years * Fibrosing PID with fibrosis score \> 10% of lung volume on chest CT scan * Be able to attend physical reconditioning 3 times a week * Be affiliated to a health insurance scheme * Sign informed consent form Exclusion Criteria: * Any contraindication …
Contacts

No contact information available.